Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIOR
BIOR | US
4.54
USD0.24
5.58%
BIOR | US
About BIOR
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
4.54
Open
4.31
High
4.79
Low
4.15
Biora Therapeutics Inc. a biotechnology company engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity Inc. and changed its name to Biora Therapeutics Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics Inc. was founded in 2010 and is headquartered in San Diego California.
View LessBIOR | US
Risk
113.2
Sharpe
-0.75
Luna's Score
49/100
Recommendation
Hold
Luna says (BIOR | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
129.7%1 month
113.2%3 months
79.4%6 months
86.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-0.53
Debt to assets
2.57
Ent. to EBITDA
-2.03
Ent. to rev.
73.43
PEG
-
Other Fundamentals
EBITDA
-67.51M
MarketCap
165.57M
MarketCap(USD)
165.57M
Div. yield
-
Op. margin
-4.96K
Erngs. growth
-
Rev. growth
15.80K
Ret. on equity
-
Short ratio
10.14
Short perc.
12.14
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
5.20
Range1M
5.22
Range3M
5.22
Volumes: Market Activity
Rel. volume
2.52
Price X volume
524.73K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.03 | - | Cheaper |
| Ent. to Revenue | 73.43 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 79.42 | - | Par |
| Debt to Equity | -0.53 | -1.23 | Expensive |
| Debt to Assets | 2.57 | 0.25 | Expensive |
| Market Cap | 165.57M | - | Emerging |
